We await further updates then ,
Further updates will be provided as information is released by the relevant agencies.
All clinical data to date on DMX-200 demonstrates an exceptionally strong safety profile, with no serious adverse events related to the drug reported, and that the DMX-200 clinical benefit has outweighed any risks to date.
The positive signals suggest that treatment with DMX-200 may indeed result in clinically meaningful improvements in kidney function in FSGS patients.
I'm full to the gunnels...
Hope you have a relaxing weekend with friends and family , NZT
- Forums
- ASX - By Stock
- DXB
- Ann: DMX-200 Remains Eligible for Accelerated Approval
Ann: DMX-200 Remains Eligible for Accelerated Approval, page-15
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $253.1M |
Open | High | Low | Value | Volume |
47.0¢ | 49.0¢ | 45.5¢ | $1.771M | 3.761M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 34765 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 26998 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34765 | 0.460 |
1 | 27490 | 0.455 |
11 | 139304 | 0.450 |
6 | 137675 | 0.445 |
9 | 106127 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 26998 | 1 |
0.470 | 76998 | 2 |
0.475 | 60000 | 2 |
0.480 | 128862 | 3 |
0.485 | 243016 | 4 |
Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |